Balgrist Campus
Zurich, 8008, Switzerland
NCT Number: NCT05031286
Many chronic pain conditions show clear differences between between men and women, such as reported pain intensities or treatment effects, with chronic pain conditions being generally more frequent in women. Yet, the underlying mechanisms causing these differences are poorly understood. Central sensitization (CS) is considered one important mechanism in pain patients which differs between female and male patients. The central hypothesis is that already in the healthy population CS processes are more pronounced in women than in men.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Zurich, 8008, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of thermal stimuli of different intensities to the skin
Time frame: 10-20 minutes before intervention (baseline) and 20-30 minutes after intervention
Mapping of hypersensitivity in cm2 of sensitized skin area using two quantitative sensory testing tools (256mN von Frey filament and 200-400mN brush) before and after intervention
Time frame: 5-10 minutes before intervention (baseline) and 30-35 minutes after intervention
Repetitive suprathreshold elicitation of the NWR to monitor its characteristics (such as magnitude and number of responses) before and after intervention
Balgrist University Hospital
Other
Differences in Sensitization Between Men and Women After Cutaneous Thermal Stimuli
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04757987
Behavior, Central Sensitisation
[City Withheld Due to Risk to Participants], Western Cape, South Africa
View Trial DetailsNCT06127693
Adverse Childhood Experiences, Central Sensitisation
Cape Town, Western Cape, South Africa
View Trial DetailsNCT06964360
Behavior, Central Sensitisation
Badalona, Barcelona, Spain
View Trial DetailsNCT03216330
Central Sensitisation, Dyspareunia
Vancouver, British Columbia, Canada
View Trial Details